Reperfusion-Induced Endothelial Cell Dysfunction
再灌注诱导的内皮细胞功能障碍
基本信息
- 批准号:6621054
- 负责人:
- 金额:$ 32.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-12-01 至 2003-09-30
- 项目状态:已结题
- 来源:
- 关键词:antibody receptor antioxidants apoptosis cellular pathology cytotoxicity enzyme linked immunosorbent assay free radical oxygen free radical scavengers human tissue leukocyte adhesion molecules lipids mathematical model model design /development myocardial ischemia /hypoxia nitric oxide oxygen tension peroxidation peroxynitrites receptor expression reperfusion superoxides tissue /cell culture vascular endothelium
项目摘要
DESCRIPTION (Provided by Applicant): In myocardial ischemia-reperfusion (I/RP),
the production of reactive oxygen species (ROS), such as superoxide radicals
(023, from vascular endothelial cells (ECs) during RP is thought to play a
critical role in tissue injury. The injury is attributed partially to
peroxynitrite (ONOO-), a product of the reaction between nitric oxide (NO) and
O2-, and to the small GTPase Racl that activates the O2--producing NAD(P)H
oxidase. In vitro studies have used hypoxia/reoxygenation (H/RO) in static ECs
to simulate I/RP, ignoring possible flow effects on the cellular response. It
is known, however, that the onset of laminar shear stress triggers NO and 02-
generation, ONOO-formation and redox-sensitive gene expression. Thus, this
study aims to investigate the role of endogenous ROS on EC dysfunction
following the exposure of static hypoxic ECs to the onset of steady laminar (or
oscillatory) shear stress concurrently with oxygen readmission. It is
hypothesized that at RP, ECs will produce ROS of different levels/time profiles
resulting in different extents of dysfunction compared to RO. Production rates
of NO and 02- will be measured during RP vs. RO. EC dysfunction will be
quantified by assaying for: (a) lipid peroxidation and apoptosis/activation of
pro-apoptotic signaling molecules (such as the transcription factor NF-rB), (b)
expression of leukocyte adhesion molecules and the associated EC-neutrophil
adhesive interactions. While measuring each marker of dysfunction, inhibitors
of key ROS sources (including adenoviral expression of a dominant negative form
of Racl) and ROS scavengers (eg. a ONOO- decomposition catalyst) will help us
identify the ROS responsible for the EC injury. If the injury is inhibited by
both NO and 02- inhibitors, then ONOO-is implicated and its relative changes
(both intracellularly and extracellularly) will be monitored during RP with or
without the presence of inhibitors/scavengers. Extracellular ONOO- was shown to
be an index of loss of myocardial function, so the ONOO' concentrations that
the ECs are exposed to will be estimated using a mathematical
transport/reaction model of ROS in the extracellular space. In sum, the new RP
model will advance our knowledge on EC survival under conditions where both
changes in oxygen tension and fluid flow occur.
描述(申请人提供):在心肌缺血-再灌注(I/RP)中,
产生活性氧物种(ROS),如超氧自由基
(023),来自血管内皮细胞(ECs)在RP过程中被认为起到了
在组织损伤中起关键作用。受伤的部分原因是
过氧亚硝酸盐(ONOO-),是一氧化氮(NO)和亚硝酸根的反应产物
O2-,以及激活产生O2-的NAD(P)H的小GTP酶Rac1
氧化物酶。体外研究已在静态内皮细胞中使用缺氧/复氧(H/RO)
以模拟I/RP,忽略可能对细胞响应的流动影响。它
然而,已知层流剪应力的开始触发了NO和02-
产生、ONOO形成和氧化还原敏感基因的表达。因此,这一点
研究旨在探讨内源性ROS在EC功能障碍中的作用
在静态低氧内皮细胞暴露到稳定的层流(或
(振荡)剪切应力与氧气再吸收同时发生。它是
假设在RP,ECs将产生不同水平/时间分布的RO
导致与RO相比不同程度的功能障碍。生产率
NO和02-将在RP和RO期间进行测量。EC功能障碍将是
通过分析:(A)脂质过氧化和细胞凋亡/激活
促凋亡信号分子(如转录因子NF-Rb),(B)
白细胞黏附分子及其相关的EC-中性粒细胞的表达
粘附性相互作用。在测量每个功能障碍的标记物时,抑制剂
关键的ROS来源(包括显性负性形式的腺病毒表达
和ROS清道夫(例如ONOO分解催化剂)将帮助我们
确定造成EC伤害的ROS。如果伤害被抑制的话
NO和02-抑制物,然后ONOO-被牵连及其相关变化
(细胞内和细胞外)将在使用或
没有抑制剂/清道夫的存在。胞外ONOO-被证明是
是心肌功能丧失的一个指标,所以ONOO浓度
ECS面临的风险将使用数学公式进行估计
ROS在胞外空间的运输/反应模型。总而言之,新的RP
模型将促进我们对EC在以下条件下的生存的了解
氧气张力和液体流量会发生变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barbara Rita Alevriadou其他文献
Barbara Rita Alevriadou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barbara Rita Alevriadou', 18)}}的其他基金
Control of Endothelial Mechanotransduction by the Mitochondrial Ca2+ Uniporter: Implications for Atherosclerosis
线粒体 Ca2 单向转运蛋白控制内皮机械转导:对动脉粥样硬化的影响
- 批准号:
10423402 - 财政年份:2018
- 资助金额:
$ 32.7万 - 项目类别:
Control of Endothelial Mechanotransduction by the Mitochondrial Ca2+ Uniporter: Implications for Atherosclerosis
线粒体 Ca2 单向转运蛋白控制内皮机械转导:对动脉粥样硬化的影响
- 批准号:
10197208 - 财政年份:2018
- 资助金额:
$ 32.7万 - 项目类别:
Emerging Functions of Mitochondrial Fission in Postischemic Endothelial Cells
缺血后内皮细胞线粒体分裂的新功能
- 批准号:
8114320 - 财政年份:2011
- 资助金额:
$ 32.7万 - 项目类别:
Emerging Functions of Mitochondrial Fission in Postischemic Endothelial Cells
缺血后内皮细胞线粒体分裂的新功能
- 批准号:
8298985 - 财政年份:2011
- 资助金额:
$ 32.7万 - 项目类别:
Mechanoregulation of endothelial mitochondrial function
内皮线粒体功能的机械调节
- 批准号:
7361483 - 财政年份:2008
- 资助金额:
$ 32.7万 - 项目类别:
Mechanoregulation of endothelial mitochondrial function
内皮线粒体功能的机械调节
- 批准号:
7539922 - 财政年份:2008
- 资助金额:
$ 32.7万 - 项目类别:
Reperfusion-Induced Endothelial Cell Dysfunction
再灌注诱导的内皮细胞功能障碍
- 批准号:
6684121 - 财政年份:2001
- 资助金额:
$ 32.7万 - 项目类别:
Reperfusion-Induced Endothelial Cell Dysfunction
再灌注诱导的内皮细胞功能障碍
- 批准号:
6430262 - 财政年份:2001
- 资助金额:
$ 32.7万 - 项目类别:
Reperfusion-Induced Endothelial Cell Dysfunction
再灌注诱导的内皮细胞功能障碍
- 批准号:
6878004 - 财政年份:2001
- 资助金额:
$ 32.7万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 32.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 32.7万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 32.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 32.7万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 32.7万 - 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 32.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 32.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 32.7万 - 项目类别:
Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 32.7万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 32.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




